Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
10 pending office actions • 10 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Centre National De La Recherche Scientifique-Cnrs has 1 pending office action in the Chemistry & Materials technology area. This active matter is assigned to a distinct art unit, indicating a concentrated technical focus for the organization's current chemistry filings. The concentration in a specialized division suggests that the organization's innovations are being evaluated within a single area of the USPTO, which may lead to a highly specific examination process.
The prosecution is overseen by a distinct examiner, ZHANG, KELING NMN, who is the busiest official for the portfolio with 1 pending action. This means the immediate outcome for this organization's chemistry patent application is determined by the review and feedback of this specific examiner. Having only one official responsible for the entire active workload allows the legal team to focus exclusively on the specific preferences and procedural expectations of that individual.
While this centralized structure provides a clear point of contact, it also means the organization's current prosecution success is tied to the perspective of the assigned reviewer. Practitioners should prioritize building a thorough understanding of the technical requirements and examination style favored by ZHANG, KELING NMN. The outcome of the 1 pending action will be a significant indicator of the organization's future trajectory within the Chemistry & Materials sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 4 (40%) |
| §112 only | 2 (20%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BELLAH, JEFFREY LAWRENCE | 1 | 100.0% | +0.0% |
| LADD, CAROLYN LOUISE | 1 | 58.6% | +47.1% |
| MILLER, MICHAEL G | 1 | 52.3% | +15.6% |
| WHITEMAN, BRIAN A | 1 | 68.4% | +16.8% |
| MCKENZIE, THOMAS B | 1 | 57.5% | +22.7% |
| SAWYER, JENNIFER C | 1 | 68.4% | -8.2% |
| PHAM, KHAI QUYNH TIEN | 1 | 0.0% | +0.0% |
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| PHAKOUSONH, DARAVANH | 1 | 16.7% | +50.0% |
| CONNORS, ALEXANDRA F | 1 | 23.7% | +45.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711813 | ATTACHING NUCLEIC ACIDS TO A PLATINUM ELECTRODE | BELLAH, JEFFREY LAWRENCE | — |
| 18686290 | METHOD FOR GENERATING NANOPARTICLES ON THE SURFACE OF A SUBSTRATE AND PART COMPRISING SUCH A SUBSTRATE | MILLER, MICHAEL G | — |
| 18546348 | A PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLAMINES FROM POLYFLUOROALKYLALCOHOLS | SAWYER, JENNIFER C | — |
| 18029964 | PROCESS FOR SELECTION OF APTAMERS, RIBOSWITCHES AND DESOXYRIBOSWITCHES | PHAM, KHAI QUYNH TIEN | — |
| 17632201 | HARDWARE ARCHITECTURE FOR SPIKING NEURAL NETWORKS AND METHOD OF OPERATING | PHAKOUSONH, DARAVANH | — |
| 16625834 | Method for Obtaining Haploid Cells | CONNORS, ALEXANDRA F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18289512 | MESOPOROUS SOLID FOR CONTROLLING HUMIDITY IN ENCLOSED SPACES | MCKENZIE, THOMAS B | 17d overdue |
| 18001420 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT | NOTTINGHAM, KYLE GREGORY | 28d |
| 18700877 | SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS | LADD, CAROLYN LOUISE | — |
| 18686290 | METHOD FOR GENERATING NANOPARTICLES ON THE SURFACE OF A SUBSTRATE AND PART COMPRISING SUCH A SUBSTRATE | MILLER, MICHAEL G | — |
| 18418493 | ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES | WHITEMAN, BRIAN A | — |
| 17632201 | HARDWARE ARCHITECTURE FOR SPIKING NEURAL NETWORKS AND METHOD OF OPERATING | PHAKOUSONH, DARAVANH | — |
| 16625834 | Method for Obtaining Haploid Cells | CONNORS, ALEXANDRA F | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| 1622 | 1 |
| 1787 | 1 |
| 1636 | 1 |
| 1776 | 1 |
| 1691 | 1 |
| 1684 | 1 |
| 1621 | 1 |
| 2121 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18711813 | ATTACHING NUCLEIC ACIDS TO A PLATINUM ELECTRODE | BELLAH, JEFFREY LAWRENCE | 1683 | §103§112 | Non-Final OA | — | Pending | May 20, 2024 |
| 18700877 | SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS | LADD, CAROLYN LOUISE | 1622 | §103 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18686290 | METHOD FOR GENERATING NANOPARTICLES ON THE SURFACE OF A SUBSTRATE AND PART COMPRISING SUCH A SUBSTRATE | MILLER, MICHAEL G | 1787 | §102§103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18418493 | ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES | WHITEMAN, BRIAN A | 1636 | §112 | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18289512 | MESOPOROUS SOLID FOR CONTROLLING HUMIDITY IN ENCLOSED SPACES | MCKENZIE, THOMAS B | 1776 | §103 | Final Rejection | 17d overdue | Pending | Nov 03, 2023 |
| 18546348 | A PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLAMINES FROM POLYFLUOROALKYLALCOHOLS | SAWYER, JENNIFER C | 1691 | §103§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18029964 | PROCESS FOR SELECTION OF APTAMERS, RIBOSWITCHES AND DESOXYRIBOSWITCHES | PHAM, KHAI QUYNH TIEN | 1684 | §101§102§112 | Non-Final OA | — | Pending | Apr 03, 2023 |
| 18001420 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT | NOTTINGHAM, KYLE GREGORY | 1621 | §112 | Non-Final OA | 28d | Pending | Dec 09, 2022 |
| 17632201 | HARDWARE ARCHITECTURE FOR SPIKING NEURAL NETWORKS AND METHOD OF OPERATING | PHAKOUSONH, DARAVANH | 2121 | §103 | Non-Final OA | — | Pending | Feb 01, 2022 |
| 16625834 | Method for Obtaining Haploid Cells | CONNORS, ALEXANDRA F | 1634 | §103 | Final Rejection | — | Pending | Dec 23, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentre National De La Recherche Scientifique (Cnrs) has 10 pending office actions as of October 2026, spread across 10 art units and 10 examiners.
Jeffrey Lawrence Bellah has the most, with 1 of Centre National De La Recherche Scientifique (Cnrs)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
